Brian Cheng Analyst PerformanceBiotech Analyst at JPMorgan Chase & Co.Brian Cheng is a stock analyst at JPMorgan Chase & Co. focused in the healthcare sector, covering 27 publicly traded companies. Over the past year, Brian Cheng has issued 38 stock ratings, including buy, hold, and sell recommendations. While full access to Brian Cheng's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Brian Cheng's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings47 Last 1 YearsBuy Recommendations76.60% 36 Buy RatingsCompanies Covered27 Unique Companies Ratings Distribution47RatingsDistribution of strong buy, buy, hold, and sell ratings by Brian Cheng.RatingPercentageCount Strong Buy0.0%0 ratings Buy76.6%36 ratings Hold17.0%8 ratings Sell6.4%2 ratingsOut of 47 total stock ratings issued by Brian Cheng at JPMorgan Chase & Co., the majority (76.6%) have been Buy recommendations, followed by 17.0% Hold and 6.4% Sell.Best & Worst CallsBest Call0000.0%IMVTAug 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%AAPGMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ27 companiesBrian Cheng, an analyst at JPMorgan Chase & Co., currently covers 27 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare26 companies96.3%Miscellaneous1 company3.7%Brian Cheng of JPMorgan Chase & Co. specializes in stock coverage within the Healthcare sector, with additional focus on companies.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY25 companies92.6%Miscellaneous1 company3.7%HEALTHCARE PROVIDERS & SERVICES1 company3.7% Brian Cheng's Ratings History at JPMorgan Chase & Co. Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsZYMEZymeworks9/3/2026Boost Price Target$29.90$33.00Overweight$0.0000.00% ROIXNCRXencor9/3/2026Boost Price Target$26.62$21.00Neutral$0.0000.00% ROIBLSMBlossomHill Therapeutics9/1/2026Initiated Coverage$18.30$28.00Overweight$0.0000.00% ROIODTXOdyssey Therapeutics8/7/2026Boost Price Target$21.95$29.00Overweight$0.0000.00% ROITGTXTG Therapeutics8/7/2026Boost Price Target$49.52$72.00Overweight$0.0000.00% ROIGLUEMonte Rosa Therapeutics8/7/2026Lower Price Target$16.01$27.00Overweight$0.0000.00% ROIIMVTImmunovant8/4/2026Boost Price Target$39.69$50.00Overweight$0.0000.00% ROISTTKShattuck Labs7/24/2026Initiated Coverage$7.09$10.00Overweight$0.0000.00% ROIARWRArrowhead Pharmaceuticals7/17/2026Boost Price Target$73.43$95.00Overweight$0.0000.00% ROITNGXTango Therapeutics7/15/2026Initiated Coverage$29.65$46.00Overweight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. ODTXOdyssey Therapeutics6/2/2026Initiated Coverage$16.96$26.00Overweight$0.0000.00% ROITARAProtara Therapeutics5/14/2026Lower Price Target$5.23$26.00Overweight$0.0000.00% ROIKYTXKyverna Therapeutics5/13/2026Lower Price Target$10.44$29.00Overweight$0.0000.00% ROICGONCG Oncology5/11/2026Boost Price Target$69.11$96.00Overweight$0.0000.00% ROIGLUEMonte Rosa Therapeutics5/11/2026Boost Price Target$20.30$31.00Overweight$0.0000.00% ROIXNCRXencor5/11/2026Boost Price Target$12.83$14.00Neutral$0.0000.00% ROIARWRArrowhead Pharmaceuticals5/1/2026Initiated Coverage$73.48$88.00Overweight$0.0000.00% ROICGONCG Oncology4/17/2026Boost Price Target$68.99$91.00Overweight$0.0000.00% ROIALLOAllogene Therapeutics4/16/2026Upgrade$2.17Neutral$0.0000.00% ROIXNCRXencor3/24/2026Reiterated Rating$12.05$13.00Neutral$0.0000.00% ROIPTGXProtagonist Therapeutics3/19/2026Boost Price Target$101.85$106.00Overweight$0.0000.00% ROITARAProtara Therapeutics3/4/2026Initiated Coverage$6.15$27.00Overweight$0.0000.00% ROIEIKNEikon Therapeutics3/2/2026Initiated Coverage$13.78$29.00Overweight$0.0000.00% ROITGTXTG Therapeutics2/2/2026Lower Price Target$29.10$46.00Overweight$0.0000.00% ROIKYMRKymera Therapeutics12/10/2025Boost Price Target$87.77$125.00Overweight$0.0000.00% ROIOPKOPKO Health11/20/2025Initiated Coverage$1.31Neutral$0.0000.00% ROINTLAIntellia Therapeutics11/7/2025Reiterated Rating$12.32$5.00Underweight$0.0000.00% ROIPTGXProtagonist Therapeutics11/7/2025Boost Price Target$79.83$81.00Overweight$0.0000.00% ROIRVMDRevolution Medicines11/6/2025Boost Price Target$61.38$82.00Overweight$0.0000.00% ROIXNCRXencor11/6/2025Lower Price Target$14.00$18.00Overweight$0.0000.00% ROIZYMEZymeworks10/16/2025Boost Price Target$18.62$23.00Overweight$0.0000.00% ROIALLOAllogene Therapeutics10/10/2025Reiterated Rating$1.51Underweight$0.0000.00% ROIPLRXPliant Therapeutics10/10/2025Reiterated Rating$1.54Underweight$0.0000.00% ROIABSIAbsci10/2/2025Initiated Coverage$3.13Overweight$0.0000.00% ROIIMVTImmunovant9/30/2025Lower Price Target$16.06$33.00Overweight$0.0000.00% ROICGONCG Oncology9/26/2025Boost Price Target$36.48$47.00Overweight$0.0000.00% ROICRSPCRISPR Therapeutics9/18/2025Initiated Coverage$59.07$70.00Overweight$0.0000.00% ROIROIVRoivant Sciences9/18/2025Boost Price Target$15.42$20.00Overweight$0.0000.00% ROIPGENPrecigen8/15/2025Upgrade$1.85Neutral$0.0000.00% ROIIMVTImmunovant8/12/2025Lower Price Target$15.26$37.00Overweight$00.0000.00% ROIWhy major institutions are piling into this digital asset now (Ad)BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid. The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned.Get the name, the ticker, and exactly how to buy itIMNMImmunome8/7/2025Lower Price Target$9.87$22.00Overweight$00.0000.00% ROIALLOAllogene Therapeutics8/4/2025Reiterated Rating$1.08Neutral$0.0000.00% ROICGONCG Oncology5/2/2025Initiated Coverage$27.74$41.00Overweight$00.0000.00% ROIAAPGAscentage Pharma Group International3/27/2025Initiated Coverage$18.37Overweight$00.0000.00% ROIPTGXProtagonist Therapeutics3/4/2025Boost Price Target$38.50$57.00Overweight$00.0000.00% ROINTLAIntellia Therapeutics2/28/2025Reiterated Rating$10.86$13.00Neutral$00.0000.00% ROIPTGXProtagonist Therapeutics2/4/2025Boost Price Target$37.66$53.00Overweight$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital MarketsMizuho Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
